CEO Message
CEO Message
- Message from CEO
Seoul Pharmaceuticals is founded in 1976 and listed on KOSDAQ in 2000. We manufacture and distribute pharmaceutical products both for
domestic and overseas markets. We position ourselves as an outstanding company with global GMP level products. We now focus more on
specialized products with our platform technology such as ODF (Orally Disintegrating Film).
Besides a well-established domestic sales platform, we expand markets worldwide with our products. After long years of R&D for ODF, we enter
into supply agreements with Pfizer and Sandoz, followed by a series of supply agreement with partners in China and middle-east countries. We
are also in talks with a number of players globally to penetrate further new markets with our commercialized and patented ODF products.
We completed relocation of our new cGMP grade plant to the Osong Bio-medical Complex. Also, we strive for modified products which enhance
patients' compliance and convenience, working with our R&D center.
We move forward with belief in value of ‘Contribution to society we live with our innovative products’ as our company slogan, “Steady steps.
Healthier world”.
Thank you.
- CEO
- DongHyun Yoon
Company History-
Aug.
1976
Founded Seoul New Drug Industry
-
Dec.
1985
Transformed into corporate firm as Seoul Pharma Co.,Ltd
-
Nov.
1992
Approved KGMP by KFDA
-
Oct.
1996
Plant expansion and relocation to Sihwa Industrial Complex (Siheung, Gyeonggi-Do)
-
Feb.
1997
Founded Seoul Pharmaceuticals R&D center
-
Aug.
2000
Listed on the KOSDAQ
-
Aug.
2006
Developed molecular targets RhoB for first-in-class oncology drug
-
Apr.
2008
Introduction of Fair Trade Compliance Program (CP)
-
May.
2012
Approved Sildenafil citrate ODF as Smart Film® Technology
-
Nov.
2012
Agreed with PFIZER for the exclusive supply of Sildenafil ODF in Republic Of Korea
-
Feb.
2013
Won the Korea NEW Drug Development Award Technology Export
-
Mar.
2013
Completed construction of new cGMP grade factory in Osong Bio-medical complex
-
May.
2015
Approved PIC/S GMP for Osong plant by MFDS
-
Jul.
2016
Agreed with Sandoz AG for the supply of Tadalafil ODF and Sildenafil ODF in East-asian countries
-
Jun.
2017
Signed a supply agreement with GHC(China) : $100MM for 10 years
-
Oct.
2017
Agreed with SOHO for the exclusive supply of Donepezil ODF and Aripiprazole ODF in Indonesia
-
Nov.
2017
Agreed with SAJA for the exclusive supply of Tadalafil ODF in 8 GCC countries
-
Jul.
2018
Agreed with DISTOLOZA for the exclusive supply of Tadalafil ODF in Peru
- CONTACT US
-
Seoul head office.
21, Banpo-daero, Seocho-gu, Seoul, 06710, Republic of Korea
Tel. + 82.2.3470.2300
Fax. + 82.2.597.1925
Email. overseas@seoulpharma.com
-
Osong plant.
124-31, Osongsaengmyeoung 6-ro, Osong-eup, Heungdeok-gu,Cheongju-si,
Chungcheongbuko-do, 281 58, Republic of Korea
Tel. + 82.43.715.5800
Fax. + 82.43.715.5801
Email. overseas@seoulpharma.com
-
R&D center.
401, Simin-daero, Dongan-gu, Anyang-si, Gyeonggi-do, Republic of Korea
(Daeryung Techno Town 15th Room No.606)
Tel. + 82.31.348.0670
Fax. + 82.31.348.0007
Email. overseas@seoulpharma.com
